Home » Glaxo Seeks Guidance From Health Systems
Glaxo Seeks Guidance From Health Systems
British pharmaceutical giant GlaxoSmithKline is taking the unusual step of giving government health-care systems a say in deciding which drugs advance in its research pipeline, a move it hopes will result in more products these customers will pay for.
WSJ.com
WSJ.com
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May